The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Prognostic implications of EGFR protein expression in sporadic colorectal tumors: Correlation with copy number status, mRNA levels and miRNA regulation
Open accessAbstract
Sporadic colorectal cancer (sCRC) is the third most frequent cancer worldwide and the second most common cause of cancer-related deaths (mainly due metastatic dissemination). We investigated the immunohistochemical expression of frequently altered proteins in primary tumors from 51 patients (25 liver metastatic and 26 non-metastatic cases) with a median 103 months follow-up (103 months). We evaluated EGFR copy number (using SNP arrays and FISH) and its expression and regulation (by mRNA and miRNA arrays). We found differences between metastatic and non-metastatic sCRCs for MLH1 (p = 0.05), PMS2 (p = 0.02), CEA (p < 0.001) and EGFR (p < 0.001) expression. EGFR expression was associated with lymph node metastases (p = 0.001), liver metastases at diagnosis (p < 0.001), and advanced stage (p < 0.001). There were associations between EGFR expression-, EGFR gene copy number- and EGFR mRNA levels. We found potential interactions of two miRNAs targeting EGFR expression, (miR-134 and miR-4328, in non-metastatic and metastatic tumors, respectively). EGFR expression was associated with a worse outcome (p = 0.005). Multivariate analysis of prognostic factors for overall survival identified that, the expression of EGFR expression (p = 0.047) and pTNM stage (p < 0.001) predicted an adverse outcome. EGFR expression could be regulated by amplification or polysomies (in metastatic tumors), or miRNAs (miRNA-134, in non-metastatic tumors). EGFR expression in sCRC appears to be related to metastases and poor outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Copy number alterations (CNAs) and EGFR gene expression levels detected in primary tumors from patients with metastatic and non-metastatic sCRC. CNA status assessed by Affymetrix 500‐K single nucleotide polymorphism (SNP)‐array platform (panel A) and FISH techniques [probes for identifying chromosome 7 centromere (7p11; green spots) and EGFR gene (7p11.2; red spots)] (panel B). EGFR gene expression profile analyzed by oligonucleotide arrays (Affymetrix PrimeView Human Gene Expression microarray) (panel C) and immunostaining techniques (20x) (panel D). Panel (B,D) correspond to a sample of the same patient.](https://figures.cochat.ai/paper-figures/396346301ae74a14b4ecca6168e460f7/prognostic-implications-of-egfr-protein-expression-in-sporadic-colorectal-tumors-figure-2.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Epidermal growth factor (EGF) receptor (EGFR/ErbB1/HER1) is widely expressed in CRC, and its elevated expression is associated with metastases and poor outcomes [25].”
From Recent Advances in Therapeutic Strategies to Improve Colorectal Cancer Treatment (2024) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Egner, J. R. (2010) · JAMA · doi:10.1001/jama.2010.1525 · Cited by 5,997
TM4: a free, open-source system for microarray data management and analysis
Saeed, A. I., Sharov, V., White, J., Li, J., Liang, W., Bhagabati, N., Braisted, J., Klapa, M., Currier, T., Thiagarajan, M., et al. (2003) · BioTechniques · doi:10.2144/03342mt01 · Cited by 4,837
Microsatellite Instability in Colorectal Cancer
Boland, C. R., & Goel, A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.064 · Cited by 2,456
Global cancer statistics in the year 2000
Parkin, D. M. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(01)00486-7 · Cited by 2,445
Dweep, H., Sticht, C., Pandey, P., & Gretz, N. (2011) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2011.05.002 · Cited by 1,696
miRecords: an integrated resource for microRNA-target interactions
Xiao, F., Zuo, Z., Cai, G., Kang, S., Gao, X., & Li, T. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn851 · Cited by 1,438
Prognostic Factors in Prostate Cancer: College of American Pathologists Consensus Statement 1999
Bostwick, D. G., Grignon, D. J., Hammond, M. E. H., Amin, M. B., Cohen, M., Crawford, D., Gospadarowicz, M., Kaplan, R. S., Miller, D. S., Montironi, R., et al. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0995-pfipc · Cited by 1,239
Prognostic Factors in Colorectal Cancer: College of American Pathologists Consensus Statement 1999
Compton, C. C., Fielding, L. P., Burgart, L. J., Conley, B., Cooper, H. S., Hamilton, S. R., Hammond, M. E. H., Henson, D. E., Hutter, R. V. P., Nagle, R. B., et al. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0979-pficc · Cited by 1,230
Research works printed but not linked: 2
- Kaserer, K. et al. Staining patterns of p53 immunohistochemistry and their biological significance in colorectal cancer. J. Pathol. 190(4), 450–6 (2000). · doi:10.1002/(sici)1096-9896(200003)190:4<450::aid-path545>3.0.co;2-8
- Goldstein, N. S. & Armin, M. Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinoma: implications for a standardized scoring system. Cancer 92(5), 1331–46 (2001). · DOI · Paper page
Cited by
Recent Advances in Therapeutic Strategies to Improve Colorectal Cancer Treatment
Gmeiner, W. H. (2024) · Cancers · doi:10.3390/cancers16051029 · Cited by 78
The Current Landscape of Antibody-based Therapies in Solid Malignancies
Shah, A., Rauth, S., Aithal, A., Kaur, S., Ganguly, K., Orzechowski, C., Varshney, G. C., Jain, M., & Batra, S. K. (2020) · Theranostics · doi:10.7150/thno.52614 · Cited by 55
“A clinically relevant example for this is seen by a better response of cetuximab or panitumumab in metastatic colorectal cancer patients having higher EGFR gene copy numbers [45, 47].”
BackgroundPersonalized Immunotherapy in Colorectal Cancers: Where Do We Stand?
Hu, L., Lan, H., Huang, D., Li, X., & Jin, K. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.769305 · Cited by 37
Hao, M., Wang, K., Ding, Y., Li, H., Liu, Y., & Ding, L. (2022) · European journal of medical research · doi:10.1186/s40001-022-00759-z · Cited by 31
An amino acid transporter subunit as an antibody–drug conjugate target in colorectal cancer
Montero, J. C., del Carmen, S., Abad, M., Sayagués, J. M., Barbáchano, A., Fernández‐Barral, A., Múñoz, A., & Pandiella, A. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02784-0 · Cited by 15
“The tissue microarray (TMA) used to analyze levels of CD98hc in 26 primary tumors, 34 liver metastases and 16 lymph node metastases by Immunohistochemical was created as described [44].”
MethodSelf-citation
Metadata
- Authors
- del Carmen, S., Corchete, L. A., Gervas, R., Rodriguez, A., Garcia, M., Álcazar, J. A., García, J., Bengoechea, O., Muñoz-Bellvis, L., Sayagués, J. M., & Abad, M.
- Affiliations
- Universidad de Salamanca (ES)
- Corresponding author
- Sayagués, José María
- Abad, Mar
- Venue
- Scientific Reports
- Published
- 2020-03-13
- Volume
- 10
- Issue
- 1
- Pages
- 4662-4662
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC7070091
- OpenAlex
- W3011667214
- Cited by
- 18
- References
- 73
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 5 · 2022: 6 · 2021: 3 · 2020: 2
- FWCI
- 1.81
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Hispana (publishedVersion, cc-by-nc-nd)
- Gredos (University of Salamanca) (submittedVersion, cc-by-nc-nd)
- Funders
- Centro de Investigación Biomédica en Red de Cáncer (CB16/12/00400)
- Instituto de Salud Carlos III (CB16/12/00400)
- Topics
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
- Keywords
- sporadic colorectal cancer, EGFR expression, EGFR gene copy number, microRNA regulation, miR-134, liver metastasis, lymph node metastasis, prognostic factors, overall survival, MLH1, PMS2, CEA, gene amplification, polysomy, TNM stage
- MeSH terms
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Neoplasm Metastasis, Neoplasm Staging, Prognosis, Colorectal Neoplasms, Gene Expression Regulation, Neoplastic, Survival Analysis, Gene Expression Profiling, MicroRNAs, DNA Copy Number Variations, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prognostic implications of EGFR protein expression in sporadic colorectal tumors: Correlation with copy number status, mRNA levels and miRNA regulation. https://app.cochat.ai/papers/10.1038/s41598-020-61688-7
- The paper
- del Carmen, S., Corchete, L. A., Gervas, R., Rodriguez, A., Garcia, M., Álcazar, J. A., García, J., Bengoechea, O., Muñoz-Bellvis, L., Sayagués, J. M., & Abad, M. (2020). Prognostic implications of EGFR protein expression in sporadic colorectal tumors: Correlation with copy number status, mRNA levels and miRNA regulation. Scientific Reports. https://doi.org/10.1038/s41598-020-61688-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.